Clinical parameters affecting multipotent adult progenitor cells in vitro

BACKGROUND: Human multipotent adult progenitor cells (MAPC®) are an emerging therapy for traumatic brain injury (TBI); however, clinically translating a therapy involves overcoming many factors in vivo which are not present in pre-clinical testing. In this study we examined clinical parameters in vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, Margaret L., Ruppert, Katherine A., Kota, Daniel J., Prabhakara, Karthik S., Hetz, Robert A., Aertker, Benjamin M., Bedi, Supinder, Mays, Robert W., Olson, Scott D., Cox, Charles S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812213/
https://www.ncbi.nlm.nih.gov/pubmed/31667385
http://dx.doi.org/10.1016/j.heliyon.2019.e02532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812213/
https://www.ncbi.nlm.nih.gov/pubmed/31667385
http://dx.doi.org/10.1016/j.heliyon.2019.e02532

Ejemplares similares